Provectus Biopharmaceuticals PVCT
OTC PVCT
$0.05 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Provectus Biopharmaceuticals (PVCT) Accumulated Expenses (2019 - 2026)

Updated

Analysis

Provectus Biopharmaceuticals (PVCT) Accumulated Expenses (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Provectus Biopharmaceuticals 21.01 Mn 19.10 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 163,623.00
Dec 31, 2025 143,924.00
Sep 30, 2025 141,583.00
Jun 30, 2025 148,212.00
Mar 31, 2025 152,145.00
Dec 31, 2024 172,687.00
Sep 30, 2024 133,699.00
Jun 30, 2024 151,106.00
Mar 31, 2024 151,574.00
Dec 31, 2023 22,600.00
Sep 30, 2023 13,867.00
Jun 30, 2023 4,433.00
Mar 31, 2023 39,267.00
Dec 31, 2022 30,844.00
Sep 30, 2022 104,589.00
Jun 30, 2022 68,389.00
Mar 31, 2022 35,856.00
Dec 31, 2021 10,578.00
Mar 31, 2021 3.13 Mn
Dec 31, 2020 2.77 Mn
API Access

Provectus Biopharmaceuticals Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=PVCT&period=max&api_key=YOUR_API_KEY